RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146

Yoshinori Matsumoto, Jose Larose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc D. Grynpas, Feng Cong, Robert Rottapel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Bone undergoes continuous remodeling due to balanced bone formation and resorption mediated by osteoblasts and osteoclasts, respectively. Osteoclasts arise from the macrophage lineage, and their differentiation is dependent on RANKL, a member of the TNF family of cytokines. Here, we have provided evidence that RANKL controls the expression of 3BP2, an adapter protein that is required for activation of SRC tyrosine kinase and simultaneously coordinates the attenuation of ?-catenin, both of which are required to execute the osteoclast developmental program. We found that RANKL represses the transcription of the E3 ubiquitin ligase RNF146 through an NF-?B-related inhibitory element in the RNF146 promoter. RANKL-mediated suppression of RNF146 results in the stabilization of its substrates, 3BP2 and AXIN1, which consequently triggers the activation of SRC and attenuates the expression of ?-catenin, respectively. Depletion of RNF146 caused hypersensitivity to LPS-induced TNF-? production in vivo. RNF146 thus acts as an inhibitory switch to control osteoclastogenesis and cytokine production and may be a control point underlying the pathogenesis of chronic inflammatory diseases.

Original languageEnglish
Pages (from-to)1303-1315
Number of pages13
JournalJournal of Clinical Investigation
Volume127
Issue number4
DOIs
Publication statusPublished - Apr 3 2017
Externally publishedYes

Fingerprint

Osteoclasts
Ligases
Ubiquitin
Catenins
Osteogenesis
Cytokines
Ubiquitin-Protein Ligases
Bone Resorption
Osteoblasts
Protein-Tyrosine Kinases
Hypersensitivity
Chronic Disease
Macrophages
Bone and Bones
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146. / Matsumoto, Yoshinori; Larose, Jose; Kent, Oliver A.; Lim, Melissa; Changoor, Adele; Zhang, Lucia; Storozhuk, Yaryna; Mao, Xiaohong; Grynpas, Marc D.; Cong, Feng; Rottapel, Robert.

In: Journal of Clinical Investigation, Vol. 127, No. 4, 03.04.2017, p. 1303-1315.

Research output: Contribution to journalArticle

Matsumoto, Y, Larose, J, Kent, OA, Lim, M, Changoor, A, Zhang, L, Storozhuk, Y, Mao, X, Grynpas, MD, Cong, F & Rottapel, R 2017, 'RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146', Journal of Clinical Investigation, vol. 127, no. 4, pp. 1303-1315. https://doi.org/10.1172/JCI90527
Matsumoto, Yoshinori ; Larose, Jose ; Kent, Oliver A. ; Lim, Melissa ; Changoor, Adele ; Zhang, Lucia ; Storozhuk, Yaryna ; Mao, Xiaohong ; Grynpas, Marc D. ; Cong, Feng ; Rottapel, Robert. / RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146. In: Journal of Clinical Investigation. 2017 ; Vol. 127, No. 4. pp. 1303-1315.
@article{051b63005a0049b58ebf3c9252b3384e,
title = "RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146",
abstract = "Bone undergoes continuous remodeling due to balanced bone formation and resorption mediated by osteoblasts and osteoclasts, respectively. Osteoclasts arise from the macrophage lineage, and their differentiation is dependent on RANKL, a member of the TNF family of cytokines. Here, we have provided evidence that RANKL controls the expression of 3BP2, an adapter protein that is required for activation of SRC tyrosine kinase and simultaneously coordinates the attenuation of ?-catenin, both of which are required to execute the osteoclast developmental program. We found that RANKL represses the transcription of the E3 ubiquitin ligase RNF146 through an NF-?B-related inhibitory element in the RNF146 promoter. RANKL-mediated suppression of RNF146 results in the stabilization of its substrates, 3BP2 and AXIN1, which consequently triggers the activation of SRC and attenuates the expression of ?-catenin, respectively. Depletion of RNF146 caused hypersensitivity to LPS-induced TNF-? production in vivo. RNF146 thus acts as an inhibitory switch to control osteoclastogenesis and cytokine production and may be a control point underlying the pathogenesis of chronic inflammatory diseases.",
author = "Yoshinori Matsumoto and Jose Larose and Kent, {Oliver A.} and Melissa Lim and Adele Changoor and Lucia Zhang and Yaryna Storozhuk and Xiaohong Mao and Grynpas, {Marc D.} and Feng Cong and Robert Rottapel",
year = "2017",
month = "4",
day = "3",
doi = "10.1172/JCI90527",
language = "English",
volume = "127",
pages = "1303--1315",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146

AU - Matsumoto, Yoshinori

AU - Larose, Jose

AU - Kent, Oliver A.

AU - Lim, Melissa

AU - Changoor, Adele

AU - Zhang, Lucia

AU - Storozhuk, Yaryna

AU - Mao, Xiaohong

AU - Grynpas, Marc D.

AU - Cong, Feng

AU - Rottapel, Robert

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Bone undergoes continuous remodeling due to balanced bone formation and resorption mediated by osteoblasts and osteoclasts, respectively. Osteoclasts arise from the macrophage lineage, and their differentiation is dependent on RANKL, a member of the TNF family of cytokines. Here, we have provided evidence that RANKL controls the expression of 3BP2, an adapter protein that is required for activation of SRC tyrosine kinase and simultaneously coordinates the attenuation of ?-catenin, both of which are required to execute the osteoclast developmental program. We found that RANKL represses the transcription of the E3 ubiquitin ligase RNF146 through an NF-?B-related inhibitory element in the RNF146 promoter. RANKL-mediated suppression of RNF146 results in the stabilization of its substrates, 3BP2 and AXIN1, which consequently triggers the activation of SRC and attenuates the expression of ?-catenin, respectively. Depletion of RNF146 caused hypersensitivity to LPS-induced TNF-? production in vivo. RNF146 thus acts as an inhibitory switch to control osteoclastogenesis and cytokine production and may be a control point underlying the pathogenesis of chronic inflammatory diseases.

AB - Bone undergoes continuous remodeling due to balanced bone formation and resorption mediated by osteoblasts and osteoclasts, respectively. Osteoclasts arise from the macrophage lineage, and their differentiation is dependent on RANKL, a member of the TNF family of cytokines. Here, we have provided evidence that RANKL controls the expression of 3BP2, an adapter protein that is required for activation of SRC tyrosine kinase and simultaneously coordinates the attenuation of ?-catenin, both of which are required to execute the osteoclast developmental program. We found that RANKL represses the transcription of the E3 ubiquitin ligase RNF146 through an NF-?B-related inhibitory element in the RNF146 promoter. RANKL-mediated suppression of RNF146 results in the stabilization of its substrates, 3BP2 and AXIN1, which consequently triggers the activation of SRC and attenuates the expression of ?-catenin, respectively. Depletion of RNF146 caused hypersensitivity to LPS-induced TNF-? production in vivo. RNF146 thus acts as an inhibitory switch to control osteoclastogenesis and cytokine production and may be a control point underlying the pathogenesis of chronic inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=85018708083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018708083&partnerID=8YFLogxK

U2 - 10.1172/JCI90527

DO - 10.1172/JCI90527

M3 - Article

C2 - 28287403

AN - SCOPUS:85018708083

VL - 127

SP - 1303

EP - 1315

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -